Benzylamine Explained
Benzylamine is an organic chemical compound with the condensed structural formula C6H5CH2NH2 (sometimes abbreviated as PhCH2NH2 or BnNH2). It consists of a benzyl group, C6H5CH2, attached to an amine functional group, NH2. This colorless water-soluble liquid is a common precursor in organic chemistry and used in the industrial production of many pharmaceuticals. The hydrochloride salt was used to treat motion sickness on the Mercury-Atlas 6 mission in which NASA astronaut John Glenn became the first American to orbit the Earth.
Manufacturing
Benzylamine can be produced by several methods, the main industrial route being the reaction of benzyl chloride and ammonia. It is also produced by the reduction of benzonitrile and reductive amination of benzaldehyde, both done over Raney nickel.[1]
It was first produced accidentally by Rudolf Leuckart in the reaction of benzaldehyde with formamide in a process now known as the Leuckart reaction,[2] a general process in which reductive amination of aldehydes or ketones yields the corresponding amine.[3] [4]
Biochemistry
Benzylamine occurs biologically from the action of the N-substituted formamide deformylase enzyme, which is produced by Arthrobacter pascens bacteria.[5] This hydrolase catalyses the conversion of N-benzylformamide into benzylamine with formate as a by-product.[6] Benzylamine is degraded biologically by the action of the monoamine oxidase B enzyme,[7] resulting in benzaldehyde.[8]
Uses
Benzylamine is used as a masked source of ammonia, since after N-alkylation, the benzyl group can be removed by hydrogenolysis:[9]
C6H5CH2NH2 + 2 RBr → C6H5CH2NR2 + 2 HBr
C6H5CH2NR2 + H2 → C6H5CH3 + R2NHTypically a base is employed in the first step to absorb the HBr (or related acid for other kinds of alkylating agents).
Benzylamine reacts with acetyl chloride to form N-benzylacetamide.
Isoquinolines can be prepared from benzylamine and glyoxal acetal by an analogous approach known as the Schlittler-Müller modification to the Pomeranz–Fritsch reaction. This modification can also be used for preparing substituted isoquinolines.[10]
Benzylamine is used in the manufacture of other pharmaceuticals, including alniditan,[11] lacosamide,[12] [13] moxifloxacin,[14] and nebivolol.[15]
Benzylamine is also used to manufacture the military explosive hexanitrohexaazaisowurtzitane (HNIW), which is superior to older nitroamine high explosives like HMX and RDX. Illustrating the debenzylation tendency of benzylamines, four of the benzyl groups are removed from hexabenzylhexaazaisowurtzitane by hydrogenolysis catalysed by palladium on carbon.[16]
Salts
The hydrochloride salt of benzylamine, C6H5CH2NH3Cl or C6H5CH2NH2·HCl,[17] is prepared by reacting benzylamine with hydrochloric acid, and can be used in treating motion sickness. NASA astronaut John Glenn was issued with benzylamine hydrochloride for this purpose for the Mercury-Atlas 6 mission.[18] The cation in this salt is called benzylammonium and is a moiety found in pharmaceuticals such as the anthelmintic agent bephenium hydroxynaphthoate, used in treating ascariasis.[19]
Other derivatives of benzylamine and its salts have been shown to have anti-emetic properties, including those with the N-(3,4,5-trimethoxybenzoyl)benzylamine moiety.[20] Commercially available motion-sickness agents including cinnarizine and meclizine are derivatives of benzylamine.
Other benzylamines
1-Phenylethylamine is a methylated benzylamine derivative that is chiral; enantiopure forms are obtained by resolving racemates. Its racemic form is sometimes known as (±)-α-methylbenzylamine.[21] Both benzylamine and 1-phenylethylamine form stable ammonium salts and imines due to their relatively high basicity.
Safety and environment
Benzylamine exhibits modest oral toxicity in rats with LD50 of 1130 mg/kg. It is readily biodegraded.[1]
Notes and References
- Book: Heuer, L. . 2006. Benzylamines . Ullmann's Encyclopedia of Industrial Chemistry . . 10.1002/14356007.a04_009.pub2 . 3527306730 .
- Crossley. F. S.. M. L.. Moore. Studies on the Leuckart Reaction. J. Org. Chem.. 1944. 9. 6. 529–536. 10.1021/jo01188a006.
- Webers. V. J.. Bruce. W. F.. The Leuckart Reaction: A study of the Mechanism. J. Am. Chem. Soc.. 1948. 70. 4. 1422–1424. 10.1021/ja01184a038. 18915755.
- Pollard. C. B.. Young. D. C.. The Mechanism of the Leuckart Reaction. J. Org. Chem.. 1951. 16. 5. 661–672. 10.1021/jo01145a001.
- Book: https://books.google.com/books?id=hN38HsVK5HgC&q=benzylformamide&pg=PA376. 3.5.1.91 N-substituted formamide deformylase. 376–378. Class 3 Hydrolases: EC 3.4.22–3.13. Springer Handbook of Enzymes. D.. Schomburg. I.. Schomburg. Chang. A.. 2nd. Springer Science & Business Media. 2009. 9783540857051.
- Fukatsu. H.. Hashimoto. Y.. Goda. M.. Higashibata. H.. Kobayashi. M.. 2004. Amine-synthesizing enzyme N-substituted formamide deformylase: screening, purification, characterization, and gene cloning. Proc. Natl. Acad. Sci.. 101. 13726–13731. 15358859. 10.1073/pnas.0405082101. 38. 518824. 2004PNAS..10113726F. free.
- Web site: MAOB: Monoamine oxidase B – Homo sapiens. National Center for Biotechnology Information. 29 December 2015. 6 December 2015.
- Tipton. K. F.. Boyce. S.. O'Sullivan. J.. Davey. G. P.. Healy. J.. 2004. Monoamine oxidases: Certainties and uncertainties. Curr. Med. Chem.. 11. 15. 1965–1982. 10.2174/0929867043364810. 15279561.
- (example of alklylation of benzylamine followed by hydrogenolysis).
- Book: Li, J. J.. Name Reactions: A Collection of Detailed Mechanisms and Synthetic Applications. 2014. Schlittler–Müller modification. Springer. 9783319039794. 492. 5th.
- The discovery of a series of new non-indole 5HT1D agonists. 1995. Lommen. G.. De Bruyn. M.. Schroven. M.. Verschueren. W.. Janssens. W.. Verrelst. J.. Leysen. J.. Bioorg. Med. Chem. Lett.. 5. 22. 2649–2654. 10.1016/0960-894X(95)00473-7.
- Choi. D.. Stables. J. P.. Kohn. H.. Synthesis and anticonvulsant activities of N-Benzyl-2-acetamidopropionamide derivatives. J. Med. Chem.. 1996. 39. 9. 1907–1916. 8627614. 10.1021/jm9508705.
- Morieux. P.. Stables. J. P.. Kohn. H.. Synthesis and anticonvulsant activities of N-benzyl-(2R)-2-acetamido-3-oxysubstituted propionamide derivatives. Bioorg. Med. Chem.. 2008. 16. 19. 8968–8975. 18789868. 10.1016/j.bmc.2008.08.055. 2701728.
- Book: Peterson, U.. https://books.google.com/books?id=FjKfqkaKkAAC&q=discovery+benzylamine&pg=PA338. 338–342. Quinolone Antibiotics: The Development of Moxifloxacin. Analogue-based Drug Discovery. IUPAC. IUPAC. J.. Fischer. C. R.. Ganellin. John Wiley & Sons. 9783527607495. 2006.
- US. 4654362. patent. Derivatives of 2,2'-iminobisethanol. 1987-03-31. 1984-10-12. 1983-12-05. Van Lommen, G. R. E.. De Bruyn, M. F. L.. Schroven, M. F. J.. Janssen Pharmaceutica, N.V.. . .
- Combust. Explos. Shock Waves. 2005. 41. 2. 121–132. Hexanitrohexaazaisowurtzitane (CL-20) and CL-20-based formulations (review). U. R.. Nair. R.. Sivabalan. G. M.. Gore. M.. Geetha. S. N.. Asthana. H.. Singh. 10.1007/s10573-005-0014-2. 95545484.
- Web site: Benzylamine hydrochloride. Sigma-Aldrich. 28 December 2015.
- Book: https://history.nasa.gov/SP-4201/ch13-2.htm. This New Ocean: A History of Project Mercury. Swenson. L. S.. J. M.. Grimwood. C. C.. Alexander. 13: Mercury Mission Accomplished (13.1 Preparing a Man to Orbit). 413–418. nasa.gov.
- Book: https://books.google.com/books?id=DYc7bY-egLEC&q=Bephenium&pg=PA35. 33–35. Handbook of Drugs for Tropical Parasitic Infections. U.. Hellgren. Ö.. Ericsson. Y.. Aden Abdi. L. L.. Gustafsson. Bephenium hydroxynaphthoate. 2nd. 2003. CRC Press. 9780203211519.
- US. 2879293. patent. Benzylamine derivatives. 1959-03-24. 1959-03-24. 1957-02-19. 1957-02-19. Sidney, T.. Goldberg, M. W.. Hoffmann La Roche. . .
- Web site: 1-Phenylethylamine. PubChem Public Chemical Database. National Center for Biotechnology Information. 29 December 2015. 26 December 2015. PubChem.